Can measuring anticoagulant activity and concentration in the body play a role in clinical use of medicines used to prevent blood clots?
NewsCorporate
Registration opens for public workshop
The European Medicines Agency (EMA) is calling for expressions of interest from experts and stakeholders to attend a workshop on the role of pharmacokinetic and pharmacodynamic (PK/PD) measurements in the clinical use of direct oral anticoagulants (DOACs) scheduled to take place in London on 23 November 2015.
The Programme - Workshop on the role of pharmacokinetic and pharmacodynamic measurements in the use of direct oral anticoagulants of the workshop is available.
Expressions of interest should be sent to DOACworkshop@ema.europa.eu by Friday, 30 October 2015, including name, company or affiliation, telephone number and e-mail address.
The objectives of the workshop are to:
A total of 50 places are available. They will be allocated to ensure a fair representation across all stakeholder groups, including regulatory, patient and healthcare professionals and pharmaceutical industry representatives. Confirmation of participation in the workshop will be sent by 6 November 2015.
The workshop will be broadcast live on the EMA website. A video recording will be made available following the event. Presentations from the workshop will also be published.